Literature DB >> 32965490

Associations Between Prenatal Cannabis Exposure and Childhood Outcomes: Results From the ABCD Study.

Sarah E Paul1, Alexander S Hatoum2, Jeremy D Fine1, Emma C Johnson2, Isabella Hansen1, Nicole R Karcher1, Allison L Moreau1, Erin Bondy1, Yueyue Qu1, Ebony B Carter3, Cynthia E Rogers2, Arpana Agrawal2, Deanna M Barch1,2, Ryan Bogdan1.   

Abstract

Importance: In light of increasing cannabis use among pregnant women, the US Surgeon General recently issued an advisory against the use of marijuana during pregnancy. Objective: To evaluate whether cannabis use during pregnancy is associated with adverse outcomes among offspring. Design, Setting, and Participants: In this cross-sectional study, data were obtained from the baseline session of the ongoing longitudinal Adolescent Brain and Cognitive Development Study, which recruited 11 875 children aged 9 to 11 years, as well as a parent or caregiver, from 22 sites across the United States between June 1, 2016, and October 15, 2018. Exposure: Prenatal cannabis exposure prior to and after maternal knowledge of pregnancy. Main Outcomes and Measures: Symptoms of psychopathology in children (ie, psychotic-like experiences [PLEs] and internalizing, externalizing, attention, thought, and social problems), cognition, sleep, birth weight, gestational age at birth, body mass index, and brain structure (ie, total intracranial volume, white matter volume, and gray matter volume). Covariates included familial (eg, income and familial psychopathology), pregnancy (eg, prenatal exposure to alcohol and tobacco), and child (eg, substance use) variables.
Results: Among 11 489 children (5997 boys [52.2%]; mean [SD] age, 9.9 [0.6] years) with nonmissing prenatal cannabis exposure data, 655 (5.7%) were exposed to cannabis prenatally. Relative to no exposure, cannabis exposure only before (413 [3.6%]) and after (242 [2.1%]) maternal knowledge of pregnancy were associated with greater offspring psychopathology characteristics (ie, PLEs and internalizing, externalizing, attention, thought and, social problems), sleep problems, and body mass index, as well as lower cognition and gray matter volume (all |β| > 0.02; all false discovery rate [FDR]-corrected P < .03). Only exposure after knowledge of pregnancy was associated with lower birth weight as well as total intracranial volume and white matter volumes relative to no exposure and exposure only before knowledge (all |β| > 0.02; all FDR-corrected P < .04). When including potentially confounding covariates, exposure after maternal knowledge of pregnancy remained associated with greater PLEs and externalizing, attention, thought, and social problems (all β > 0.02; FDR-corrected P < .02). Exposure only prior to maternal knowledge of pregnancy did not differ from no exposure on any outcomes when considering potentially confounding variables (all |β| < 0.02; FDR-corrected P > .70). Conclusions and Relevance: This study suggests that prenatal cannabis exposure and its correlated factors are associated with greater risk for psychopathology during middle childhood. Cannabis use during pregnancy should be discouraged.

Entities:  

Mesh:

Year:  2021        PMID: 32965490      PMCID: PMC7512132          DOI: 10.1001/jamapsychiatry.2020.2902

Source DB:  PubMed          Journal:  JAMA Psychiatry        ISSN: 2168-622X            Impact factor:   25.911


  70 in total

1.  Alcohol, Cigarette, and Cannabis Use Between 2002 and 2016 in Pregnant Women From a Nationally Representative Sample.

Authors:  Arpana Agrawal; Cynthia E Rogers; Christina N Lessov-Schlaggar; Ebony B Carter; Shannon N Lenze; Richard A Grucza
Journal:  JAMA Pediatr       Date:  2019-01-01       Impact factor: 16.193

2.  The Risks of Marijuana Use During Pregnancy.

Authors:  Nora D Volkow; Wilson M Compton; Eric M Wargo
Journal:  JAMA       Date:  2017-01-10       Impact factor: 56.272

3.  Impact of the home environment on the relationship between prenatal exposure to environmental tobacco smoke and child behavior.

Authors:  Madeleine B Hopson; Amy Margolis; Virginia Rauh; Julie Herbstman
Journal:  Int J Child Health Hum Dev       Date:  2016 Oct-Dec

Review 4.  Maternal and obstetric effects of prenatal drug exposure.

Authors:  R Bishai; G Koren
Journal:  Clin Perinatol       Date:  1999-03       Impact factor: 3.430

Review 5.  Polygenic Risk Scores in Clinical Psychology: Bridging Genomic Risk to Individual Differences.

Authors:  Ryan Bogdan; David A A Baranger; Arpana Agrawal
Journal:  Annu Rev Clin Psychol       Date:  2018-05-07       Impact factor: 18.561

6.  Prenatal substance exposure: effects on attention and impulsivity of 6-year-olds.

Authors:  S L Leech; G A Richardson; L Goldschmidt; N L Day
Journal:  Neurotoxicol Teratol       Date:  1999 Mar-Apr       Impact factor: 3.763

7.  Prenatal marijuana exposure, age of marijuana initiation, and the development of psychotic symptoms in young adults.

Authors:  N L Day; L Goldschmidt; R Day; C Larkby; G A Richardson
Journal:  Psychol Med       Date:  2014-12-23       Impact factor: 7.723

8.  Trends in Marijuana Use Among Pregnant and Nonpregnant Reproductive-Aged Women, 2002-2014.

Authors:  Qiana L Brown; Aaron L Sarvet; Dvora Shmulewitz; Silvia S Martins; Melanie M Wall; Deborah S Hasin
Journal:  JAMA       Date:  2017-01-10       Impact factor: 56.272

9.  Maternal tobacco, cannabis and alcohol use during pregnancy and risk of adolescent psychotic symptoms in offspring.

Authors:  Stanley Zammit; Kate Thomas; Andrew Thompson; Jeremy Horwood; Paulo Menezes; David Gunnell; Chris Hollis; Dieter Wolke; Glyn Lewis; Glynn Harrison
Journal:  Br J Psychiatry       Date:  2009-10       Impact factor: 9.319

Review 10.  The conception of the ABCD study: From substance use to a broad NIH collaboration.

Authors:  Nora D Volkow; George F Koob; Robert T Croyle; Diana W Bianchi; Joshua A Gordon; Walter J Koroshetz; Eliseo J Pérez-Stable; William T Riley; Michele H Bloch; Kevin Conway; Bethany G Deeds; Gayathri J Dowling; Steven Grant; Katia D Howlett; John A Matochik; Glen D Morgan; Margaret M Murray; Antonio Noronha; Catherine Y Spong; Eric M Wargo; Kenneth R Warren; Susan R B Weiss
Journal:  Dev Cogn Neurosci       Date:  2017-10-10       Impact factor: 6.464

View more
  27 in total

1.  Association of adverse prenatal exposure burden with child psychopathology in the Adolescent Brain Cognitive Development (ABCD) Study.

Authors:  Joshua L Roffman; Eren D Sipahi; Kevin F Dowling; Dylan E Hughes; Casey E Hopkinson; Hang Lee; Hamdi Eryilmaz; Lee S Cohen; Jodi Gilman; Alysa E Doyle; Erin C Dunn
Journal:  PLoS One       Date:  2021-04-28       Impact factor: 3.240

Review 2.  Long-term effects of prenatal cannabis exposure: Pathways to adolescent and adult outcomes.

Authors:  Natacha M De Genna; Jennifer A Willford; Gale A Richardson
Journal:  Pharmacol Biochem Behav       Date:  2022-02-22       Impact factor: 3.533

3.  Maternal cannabis use is associated with suppression of immune gene networks in placenta and increased anxiety phenotypes in offspring.

Authors:  Gregory Rompala; Yoko Nomura; Yasmin L Hurd
Journal:  Proc Natl Acad Sci U S A       Date:  2021-11-23       Impact factor: 11.205

4.  Association of Mental Health Burden With Prenatal Cannabis Exposure From Childhood to Early Adolescence: Longitudinal Findings From the Adolescent Brain Cognitive Development (ABCD) Study.

Authors:  David A A Baranger; Sarah E Paul; Sarah M C Colbert; Nicole R Karcher; Emma C Johnson; Alexander S Hatoum; Ryan Bogdan
Journal:  JAMA Pediatr       Date:  2022-09-12       Impact factor: 26.796

Review 5.  Impact of cannabinoids on pregnancy, reproductive health, and offspring outcomes.

Authors:  Jamie O Lo; Jason C Hedges; Guillermina Girardi
Journal:  Am J Obstet Gynecol       Date:  2022-05-31       Impact factor: 10.693

Review 6.  In-utero cannabis exposure and long-term psychiatric and neurodevelopmental outcomes: The limitations of existing literature and recommendations for future research.

Authors:  Ayesha C Sujan; Kelly C Young-Wolff; Lyndsay A Avalos
Journal:  Birth Defects Res       Date:  2022-06-16       Impact factor: 2.661

Review 7.  Social vulnerabilities for substance use: Stressors, socially toxic environments, and discrimination and racism.

Authors:  Hortensia Amaro; Mariana Sanchez; Tara Bautista; Robynn Cox
Journal:  Neuropharmacology       Date:  2021-03-11       Impact factor: 5.250

8.  Prenatal THC Does Not Affect Female Mesolimbic Dopaminergic System in Preadolescent Rats.

Authors:  Francesco Traccis; Valeria Serra; Claudia Sagheddu; Mauro Congiu; Pierluigi Saba; Gabriele Giua; Paola Devoto; Roberto Frau; Joseph Francois Cheer; Miriam Melis
Journal:  Int J Mol Sci       Date:  2021-02-07       Impact factor: 5.923

9.  Cannabis-related diagnosis in pregnancy and adverse maternal and infant outcomes.

Authors:  Gretchen Bandoli; Laura Jelliffe-Pawlowski; Benjamin Schumacher; Rebecca J Baer; Jennifer N Felder; Jonathan D Fuchs; Scott P Oltman; Martina A Steurer; Carla Marienfeld
Journal:  Drug Alcohol Depend       Date:  2021-05-21       Impact factor: 4.852

10.  Combined vapor exposure to THC and alcohol in pregnant rats: Maternal outcomes and pharmacokinetic effects.

Authors:  Kristen R Breit; Cristina G Rodriguez; Annie Lei; Jennifer D Thomas
Journal:  Neurotoxicol Teratol       Date:  2020-10-18       Impact factor: 3.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.